STOCKHOLDERS’ EQUITY (Tables)

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Components of Stock-Based Compensation Expenses

The following table summarizes the components of stock-based compensation expense recognized in the Company’s condensed consolidated statements of income for the periods indicated:


	Three Months Ended March 31,
	2026		2025
Cost of revenues (exclusive of depreciation and amortization)	$	22,853	$	23,923
Selling, general and administrative expenses	27,066		24,533
Total	$	49,919	$	48,456

Schedule of Service-Based Awards Activity

The table below summarizes activity related to the Company’s equity-classified and liability-classified service-based awards for the three months ended March 31, 2026:


	Equity-Classified Equity-Settled Restricted Stock Units			Liability-Classified Cash-Settled Restricted Stock Units
	Number of Shares	Weighted Average Grant Date Fair Value Per Share		Number of Shares	Weighted Average Grant Date Fair Value Per Share
Unvested service-based awards outstanding at January 1, 2026	1,467	$	230.75	106	$	238.64
Awards granted	1,114	$	137.30	83	$	137.14
Awards modified	(5)	$	224.44	5	$	141.00
Awards vested	(435)	$	245.19	(42)	$	250.04
Awards forfeited/cancelled	(21)	$	223.24	(1)	$	244.80
Unvested service-based awards outstanding at March 31, 2026	2,120	$	178.76	151	$	176.97

Schedule of Performance-Based Awards Activity

The table below summarizes activity related to the Company’s performance-based awards for the three months ended March 31, 2026:


	Equity-Classified Equity-Settled Restricted Stock Units
		Number of Shares	Weighted Average Grant Date Fair Value Per Share
Unvested performance-based awards outstanding at January 1, 2026		138	$	240.97
Awards granted		122	$	127.45
Awards vested		(4)	$	269.87
Awards forfeited/cancelled		(15)	$	231.48
Unvested performance-based awards outstanding at March 31, 2026		241	$	183.76

Schedule of Stock Options Activity

Stock option activity under the Company’s plans is set forth below:


	Number of Options	Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Term (in years)
Options outstanding at January 1, 2026	701	$	212.59

Options exercised	(56)	$	72.37

Options expired	(8)	$	296.62
Options outstanding at March 31, 2026	637	$	223.77	$	5,872	4.5

Options vested and exercisable as of March 31, 2026	580	$	216.40	$	5,872	4.2
Options expected to vest as of March 31, 2026	55	$	298.55	$	—	7.5